IO Biotech, Inc.IOBTNASDAQ
Loading
R&D Expense Growth Under PressureDecelerating
Percentile Rank20
3Y CAGR-72.4%
Year-over-Year Change
Year-over-year research & development expense growth
3Y CAGR
-72.4%/yr
Annual compound
Percentile
P20
Within normal range
vs 3Y Ago
0x
Contraction
Streak
3 yr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| 2024 | 5.39% |
| 2023 | 44.36% |
| 2022 | 55.83% |
| 2021 | 256.24% |
| 2020 | 6.64% |
| 2019 | 0.00% |